Umbilical cord blood banking – today and tomorrow
Abstract
Umbilical cord blood (UCB) is an abundant source of haematopoietic stem cells (HSC) for allogeneic HSC transplant. In addition to HSCs, the cord blood and placenta contain ample nonhaematopoietic stem cells, which increasingly raise the interest of regenerative medicine. Public UCB banks have more than 500.000 UCB units in international UCB registries that are available for the international exchange. It is estimated that additional two-fold number of units are held in the private UCB banks that store the cells for autologous purposes. Although the development of hybrid UCB banks was predicted in which the private units of UCB could be used for allogeneic purposes if needed, this has not yet happened. The activity of UCB registries is complementary to the bone marrow donor registries, which keep the data of more than 16 million donors. The key data for international exchange of UCB are the HLA typing results and the stem cell count in the UCB units. The majority of international associations and bodies do not support the autologous UCB banking based on the current poor evidence on the usefulness of autologous UCB cells. However, this opinion is changing owing to the development of regenerative medicine so changes of the ethical and expert opinions are expected. In Slovenia, the only public UCB bank is maintained at the Blood Transfusion Centre of Slovenia, whereas the only private UCB bank is Biobanka. Since unlimited expansion in the number of UCB units does not increase the like-lihood of finding HLA-identical grafts, in Slovenia we plan to collect maximum up to 2000 UCB units. In order to foster the solidarity and equal accessibility, one needs to assure the use of UCB derived cells for children and adults for their possible treatment in the future.Downloads
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.